Bill > HB951

This bill modifies Missouri law to create a regulated framework for therapeutic psilocybin use, primarily for individuals 21 years and older suffering from specific medical conditions like end-of-life care, post-traumatic stress disorder, major depressive disorder, and substance use disorders. The bill establishes detailed requirements for psilocybin use, including the need for a bona fide prescriber-patient relationship, documentation with the Department of Mental Health, and the presence of a qualified facilitator during psilocybin use. Facilitators must complete specific training programs and have expertise in the relevant medical conditions. The legislation provides legal protections for patients, facilitators, healthcare providers, and laboratories involved in psilocybin-related activities, ensuring they cannot be criminally prosecuted or professionally sanctioned for participating in these therapeutic practices. The bill also mandates confidentiality of patient information and limits psilocybin use to 150 milligrams per twelve-month period. Additionally, the bill updates definitions related to medical conditions and investigational treatments, expanding the scope of potential therapeutic interventions while maintaining safeguards for patient safety and professional standards.

https://house.mo.gov/Bill.aspx?bill=HB951&year=2025&code=R